Erythra Inc. has a Revolutionary Medical Diagnostic Solution. It has a Breakthrough in Medical Diagnostic Technology. The Erythra TB test has been manufactured and is available for distribution. Erythra can work with healthcare providers and organizations to make the test widely accessible to those who need it. The test can be used in hospitals, clinics, and other medical facilities, as well as in remote or under-resourced areas where TB is prevalent. In addition to diagnostic capabilities, the test can be used for treatment monitoring to ensure that patients are responding to therapy and for identifying a complete cure. This can help prevent the development of drug-resistant TB strains and improve patient outcomes. Diagnostic products will be able to diagnose diseases while they are in the incubation period. This is crucial in malignant diseases. The earlier the diagnosis, the more effective the treatment. Moreover, we will be able to diagnose disorders that currently have no way to be diagnosed accurately, for example, Alzheimer's disease. There are many vaccines existing that show excellent impact on health management. If we want to get rid of a particular disease we should have a good vaccine for it. For example, smallpox disappeared from the world because there was an efficient vaccine. Polio is about to disappear because of the polio vaccine. Our vision is to prepare vaccines for malignant diseases and improve the currently available vaccines. The idea is still in its infancy state and new products will be developed with the progress of our understanding of the idea. New products that can treat autoimmune disorders will be invented. Currently, there is no curing drug for those types of disorders. The treatment is based on palliative drugs.
External link for Erythra Inc.
30 Peter Coutts Circle
Stanford, California 94305, US
Seeing the large image can help in finding solutions to problems.
Antigens in hemolysate can help in developing efficient diagnostics, effective vaccines against infectious microorganisms, and effective treatment for cancers & autoimmune disorders.
Understand disease pathogenesis, not only the invasion mechanisms but also the security holes in the immune system. The security holes must exist to prevent the immune system from attacking the body and the fetus in females.
The following video describes the Erythra foundation discovery.
Antigens in hemolysate can help in developing efficient diagnostics, effective vaccines against infectious microorganisms, and effective treatment for cancers & autoimmune disorders.
The breakthrough that will improve healthcare efficiently and effectively. https://lnkd.in/dJsFsFsS
Save children from the complications of the Tuberculosis skin test.
Antigens in hemolysate can help in developing efficient diagnostics, effective vaccines against infectious microorganisms, and effective treatment for cancers & autoimmune disorders.
Isn't it time to stop injecting children with tuberculin and use a safe method? Erythra Company provides a test that uses a drop of blood and obtains the result within minutes. This test is accurate and there are no false results.